Followers | 8 |
Posts | 2298 |
Boards Moderated | 0 |
Alias Born | 01/16/2012 |
Thursday, October 30, 2014 5:48:31 PM
http://www.shareprophets.advfn.com/views/8582/txo-this-just-does-not-look-quite-tickety-boo
Their PR man contacted Share Prophets saying it was all wrong and contains lots of factual errors. Share Prophets response was write to us with the factual errors and they will correct them. 4 days later they have still heard nothing about these factual errors.
Recent TXO News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/05/2024 09:48:48 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 09:25:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:20:52 PM
- TXO Partners Declares a Fourth Quarter 2023 Distribution of $0.58 on Common Units; Files Annual Report on Form 10-K • Business Wire • 03/05/2024 09:18:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:40:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:32:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:26:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:29:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:06:45 PM
- TXO Partners Declares a Third Quarter 2023 Distribution of $0.52 on Common Units; Files Quarterly Report on Form 10-Q • Business Wire • 11/07/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:23:08 PM
- TXO Partners Declares a Second Quarter 2023 Distribution of $.48 on Common Units; Files Quarterly Report on Form 10-Q • Business Wire • 08/08/2023 08:19:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:17:24 PM
- TXO Partners Declares First Quarter 2023 Distribution of $0.50 on Common Units; Provides 2023 Distribution Outlook; Files Quarterly Report on Form 10-Q and Announces Name Change • Business Wire • 05/09/2023 08:54:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM